編者按：第24屆亞洲胸心外科協會（ASCVTS）暨第4屆亞洲單孔胸腔鏡論壇（ASPVS）於2016年4月6-10日在臺北國際會議中心舉行。正式大會在4月4月8日開幕，前兩天會議分別為海峽兩岸交流會和AATS Postgraduate course。
秉承著快樂學術、促進交流的會議報導宗旨，AME出版社以展臺為線下基地，在會議期間展開了一場「East meets West, junior meets senior」的對話運動，即由國內優秀中青年醫師組成的AME特邀記者團與國際學科意見領袖（Key opinion leader）就相關熱點話題進行訪談對話。
AME特邀記者、來自河南省腫瘤醫院的鄭燕醫師和中山大學腫瘤醫院的楊弘醫師對話長庚紀念醫院的趙盈凱（Yin-Kai Chao）教授、香港大學的Simon Law教授、上海中山醫院的譚黎傑教授，大家就兩岸三地食管癌的綜合治療進行探討。其中，香港和臺灣都是遵循NCCN指南進行術前放化療，而中國內陸很多時候都是直接行手術治療。新輔助放化療的依據來自CROSS研究，但CROSS研究和法國的9901研究對術前放化療的結果是存在矛盾的。同時CROSS研究的根治切除率過低，新輔助放化療還有很多值得探索。日本目前的標準綜合治療方案是術前化療，其1109研究將會對比術前化療與術前放化療的區別，結果會提示哪種綜合治療方案更好，我們是否能棄用術前放療。
圖1. 4月9日胸外科專場講者合影（左-右）：長庚紀念醫院的趙盈凱（Yin-Kai Chao）教授，臺大醫院李章銘教授，上海中山醫院的譚黎傑教授，香港大學的Simon YK Law教授、日本Tokai University School of Medicine的Soji Ozawa教授，韓國Yonsei University College of Medicine的Dae Joon Kim教授。
鄭燕醫師、楊弘醫師對話Yin-Kai Chao教授、Simon Law 教授和譚黎傑
圖2. 大家在採訪之後自由討論
受訪專家
Dr. Chao acquired his MD degree from Chang Gung university in 2001 and completed specialist training as thoracic surgeon in Chang Gung Memorial Hospital in 2006. In 2010, he received PhD degree in Medical sciences at the Chang Gung University. He is now the full time attending staff in the Department of Thoracic and Cardiovasvular Surgery in Chang Gung memorial hospital Linkou and an associate professor at Chang Gung University.
Dr. Chao is a board certified surgeon pioneering in minimal invasive esophagectomy. He accounts for more than 60% of the esophageal cancer operations performed annually at Chang Gung Memorial Hospital, Linkou,Taiwan. Dr. Chao is a very strong patient advocate and very dedicated to our specialty, his talent in minimal invasive surgery is outstanding and exemplary and of the highest quality.
In addition to his work, Dr Chao is also a well-known researcher . His areas of scientific investigation include the esophageal cancer research and development of biodegradable medical device. Being a recipient of numerous research awards since 2006, he has authored over 50 publications.
Dr. Yin-Kai Chao is a very well-known doctor in the esophageal cancer field. His innovative surgical methods as well as his experienced techniques have gained him recognition and praise in Taiwan.
Simon YK Law, MBBChir (Cantab), MS (HK), MA, FRCSEd, FCSHK, FHKAM, FACSProf. Law graduated from the University of Cambridge in England in 1987 with First Class Honors and completed his clinical curriculum at the same university. He received his post-graduate training at The University of Hong Kong. He became Clinical Professor in Surgery in 2005. He is currently Cheung Kung-Hai Professor in Gastrointestinal Surgery, and Chief of the Division of Esophageal and Upper Gastrointestinal Surgery at The University of Hong Kong.
Prof. Law has concentrated his experience and research in upper gastrointestinal tract disorders, with emphasis on esophageal and gastric cancers, motility disorders and gastro-esophageal reflux disease. He has focused on endoscopic diagnostic and treatment techniques on foregut diseases, surgical methods including minimally invasive and robot-assisted surgery, and multimodality treatments of esophageal and gastric cancers.
He is a council member of the College of Surgeons of Hong Kong. He plays an active role in many international societies, holding positions such as Executive Council Member of the International Society of Digestive Surgery (ISDS), Asia Representative of the Member Services Committee of the Society for Surgeons of the Alimentary Tract (SSAT). He is the current Secretary of the Hong Kong China Chapter of the American College of Surgeons.
Prof. Law has published over 400 articles and abstracts, and 30 book chapters, including those in Mastery of Surgery, Maingot’s Abdominal Operations, Pearson’s Thoracic and Esophageal Surgery and Shackelford’s Surgery of the Alimentary Tract. He is associate editor of the Diseases of the Esophagus, and editor to other leading surgical publications such as Annals of Surgery, Surgery, JAMA Surgery, and World Journal of Surgery. Professor Law is also the Editorial Board Member of the journal Translational Gastrointestinal Cancer (TGC).
主任醫師，外科學博士，博士生導師，復旦大學附屬中山醫院胸外科副主任，食管外科主任，上海市呼吸病研究所細胞與分子生物學研究室副主任。中國抗癌協會食管癌專業委員會委員、中國醫師協會胸外科分會食管外科專家委員會委員、中國醫師協會內鏡醫師分會理事、中國食管疾病學會常委（Chinese Society of Disease of the Esophagus, CSDE）、中國醫療促進會胸外科分會委員，上海市抗癌協會胸部腫瘤分會微創學組組長、上海市腫瘤學會胸部腫瘤學組委員、上海市中西醫結合學會胸外科分會常委。是ISDE、ITMIG等多個國際研究性組織成員。擔任「Journal of Thoracic Disease」、」中華胸外科雜誌」、「中國微創外科雜誌」、「食管外科」等雜誌編委及ATS, EJCTS/ITCVS, ASO, CMJ 等多本雜誌審稿人。以第一或通訊作者發表論文60餘篇，其中SCI收入20餘篇。主編「Uniportal Video-Assisted Thoracic Surgery」（中英文版）、「Uniportal Thoracoscopic Surgery」 （中英語版）、副主譯「Atlas of Minimally Invasive Esophagectomy」。主持完成科研項目「胸腹腔鏡食管癌根治術的技術優化和推廣」獲上海市醫學科技獎。
AME特邀記者|鄭燕，河南省腫瘤醫院胸外科；楊弘，中山大學腫瘤醫院胸外科。
編輯|黎少靈，AME出版社。
相關閱讀：
《單孔胸腔鏡手術》中文版+英文版組合大禮包限時超值預售中，點擊「閱讀原文」火速購買！